Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 2
2019 4
2020 3
2021 4
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Immunity to SARS-CoV-2 induced by infection or vaccination.
Castro Dopico X, Ols S, Loré K, Karlsson Hedestam GB. Castro Dopico X, et al. Among authors: ols s. J Intern Med. 2022 Jan;291(1):32-50. doi: 10.1111/joim.13372. Epub 2021 Aug 5. J Intern Med. 2022. PMID: 34352148 Free PMC article. Review.
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.
Marcandalli J, Fiala B, Ols S, Perotti M, de van der Schueren W, Snijder J, Hodge E, Benhaim M, Ravichandran R, Carter L, Sheffler W, Brunner L, Lawrenz M, Dubois P, Lanzavecchia A, Sallusto F, Lee KK, Veesler D, Correnti CE, Stewart LJ, Baker D, Loré K, Perez L, King NP. Marcandalli J, et al. Among authors: ols s. Cell. 2019 Mar 7;176(6):1420-1431.e17. doi: 10.1016/j.cell.2019.01.046. Cell. 2019. PMID: 30849373 Free PMC article.
Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response.
Glaros V, Rauschmeier R, Artemov AV, Reinhardt A, Ols S, Emmanouilidi A, Gustafsson C, You Y, Mirabello C, Björklund ÅK, Perez L, King NP, Månsson R, Angeletti D, Loré K, Adameyko I, Busslinger M, Kreslavsky T. Glaros V, et al. Among authors: ols s. Immunity. 2021 Sep 14;54(9):2005-2023.e10. doi: 10.1016/j.immuni.2021.08.017. Immunity. 2021. PMID: 34525339 Free PMC article.
Imaging the early fate of mRNA vaccines.
Ols S, Loré K. Ols S, et al. Nat Biomed Eng. 2019 May;3(5):331-332. doi: 10.1038/s41551-019-0399-y. Nat Biomed Eng. 2019. PMID: 31073175 No abstract available.
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination.
Cagigi A, Yu M, Österberg B, Svensson J, Falck-Jones S, Vangeti S, Åhlberg E, Azizmohammadi L, Warnqvist A, Falck-Jones R, Gubisch PC, Ödemis M, Ghafoor F, Eisele M, Lenart K, Bell M, Johansson N, Albert J, Sälde J, Pettie DD, Murphy MP, Carter L, King NP, Ols S, Normark J, Ahlm C, Forsell MN, Färnert A, Loré K, Smed-Sörensen A. Cagigi A, et al. Among authors: ols s. JCI Insight. 2021 Nov 22;6(22):e151463. doi: 10.1172/jci.insight.151463. JCI Insight. 2021. PMID: 34665783 Free PMC article.
Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.
Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Loré K. Lin A, et al. Among authors: ols s. J Clin Invest. 2020 May 1;130(5):2332-2346. doi: 10.1172/JCI135020. J Clin Invest. 2020. PMID: 31945015 Free PMC article. Clinical Trial.
16 results